Cellular Senescence and COVID-19

Author(s): Farhan Rahman Chowdhury, Tofazzal Islam*

Journal Name: Coronaviruses
The World's First International Journal Dedicated to Coronaviruses

Volume 2 , Issue 11 , 2021

Article ID: e310821190016
Become EABM
Become Reviewer
Call for Editor


Older adults are at a higher risk of developing serious illness and mortality from COVID-19. Among a multitude of factors, cellular senescence associated with ageing, obesity, cardiovascular diseases, and diabetes seems to be statistically correlated with severe SARS-CoV-2 infections and mortality. Surface proteins such as vimentin and CD26 that are differentially expressed on senescent cells seem important for SARS-CoV-2 attachment and internalization. Potential therapeutic agents against this novel virus also exhibit senolytic and anti-inflammatory actions, implicating that their beneficial effects could, in part, be attributed to their senescent cell removal and the associated inflammatory phenotype neutralizing properties. Elucidating the underlying molecular mechanisms that connect cellular senescence and severity of SARS-CoV-2 infection might help direct towards development of effective therapeutics for elderly patients of COVID-19.

Keywords: COVID-19, cellular senescence, ageing, SARS-CoV-2, COVID-19 therapeutics, senolytics.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2021
Published on: 08 January, 2021
Article ID: e310821190016
Pages: 4
DOI: 10.2174/2666796701666210108120344

Article Metrics

PDF: 25